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Abstract 
Chronic stroke results in significant brain tissue loss that causes permanent 
disability. Extracellular matrix (ECM) is widely used as an inductive biological 
scaffold to repair soft tissue after injury by promoting the formation of functional 
site appropriate remodeling of the injected material. However, there is a general 
lack of non-invasive imaging methods to monitor the distribution of ECM after 
injection and its biodegradation over time. Herein, we describe the use of 
diamagnetic chemical exchange saturation transfer (CEST) magnetic resonance 
imaging to monitor the distribution of an ECM hydrogel after intracerebral 
implantation into a stroke cavity. In vitro imaging indicated a robust 
concentration-dependent detection of the ECM precursor and hydrogel at 1.8 and 
3.6 ppm, which broadly corresponded to chondroitin sulfate and fibronectin. This 
detection was robust to changes in pH (5.0-7.0) and improved at 37 °C. In vivo 
implantation of an ECM hydrogel into the stroke cavity in a rat model 
corresponded macroscopically to the distribution of biomaterial as indicated by 
histology, but mismatches were also evident. Indeed, CEST imaging also 
detected an endogenous upregulation of ECM molecules in the infarct 
environment. To account for this endogenous activity, pre-implantation images 
were subtracted from post-implantation images to yield a selective visualization 
of ECM hydrogel distribution in the stroke cavity and its evolution over 7 days. 
However, the CEST detection of ECM returned to baseline within 3 days. A 
selective acute imaging of ECM hydrogel distribution within the stroke cavity is 
hence feasible, but further development is required to warrant a specific and 
selective long-term monitoring. 
 
Keywords: MRI, Extracellular Matrix, Hydrogel, Tissue Engineering, Stroke, 
Brain, Regenerative Medicine, Chemical Exchange Saturation Transfer, 
Chondroitin Sulfate, Fibronectin  
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1. Introduction 
The extracellular matrix (ECM) constitutes 20% of brain volume [1]. Stroke 
related infarcts result in the loss of neurons and other cells, but the extracellular 
matrix is gradually cleared to create an extracellular fluid (ECF)-filled tissue 
cavity [2]. Although neural stem cell transplantation in the peri-infarct tissue can 
alleviate some behavioral deficits, it does not replace lost tissue [3]. Instead, a 
structural support is required for cells within the cavity to develop a de novo 
tissue [4, 5]. Transplantation of neural stem cells in a hydrogel produced from 
extracellular matrix can efficiently repopulate the tissue cavity [6]. ECM hydrogels 
and sheets are extensively used for regenerative medicine in clinical settings to 
repair tissue defects, ranging from bladder reconstruction, muscle regeneration 
to breast reconstruction [7]. 
 ECM can be formulated to reside in a liquid phase at room temperature 
and gel at brain temperature. These gelation properties are dependent on the 
collagen concentration within the preparation. Indeed, ECM hydrogels at different 
concentrations show retention within the cavity >3 mg/mL, whereas lower 
concentrations show poor gelation and permeate into the peri-infarct tissue [8]. 
Gelation is hence a key factor in providing a structural support within the cavity. 
Injection and hence retention of the ECM at an appropriate concentration inside a 
brain cavity is challenging, because a minimally invasive approach is required to 
avoid damage to brain tissue and the skull creates a closed environment [9]. The 
use of injection-drainage, where the appropriate concentration of ECM material is 
delivered at the given concentration, while ECF is drained, can achieve complete 
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 5 
coverage of the lesion cavity [8]. However, non-invasive imaging, such as 
magnetic resonance imaging (MRI), is required to define the cavity volume, as 
well as the injection-drainage access points. 
 Injection of ECM into the fluid-filled stroke cavity changes the diffusion 
characteristics of this environment and hence provides an indirect means to 
visualize changes in this environment [6, 10]. Indeed, T2- and diffusion-weighted 
MRI have been suggested for the monitoring of tissue development from an 
acellular matrix [11, 12]. However, these measurements do not actually detect 
the material itself, nor do they afford a monitoring of the biomaterials’ 
degradation. In some cases, the biomaterial has a very distinctive MR signature 
that can be used to contrast the implant versus host tissue [13, 14]. However, 
most scaffolding material is designed to biodegrade as host cells invade the 
material and gradually replace it, hence becoming indistinguishable from host 
tissue. In these cases, MR contrast agents can be integrated into, for instance, 
hyaluronic acid (HA)-based hydrogels, to afford a specific visualization of their 
location and degradation [15, 16].  
Contrast agents only serve as a surrogate and do not directly visualize the 
injected material; similar degradation profiles are essential for these to report 
adequately on the presence of scaffolding material. Incorporation of contrast 
agents into the scaffold will further require additional safety scrutiny from 
regulators [17, 18]. Ideally, an imaging method therefore will not require the 
addition of MR contrast agents and will directly detect the injected material and 
its degradation profile. As ECM molecules are known to have MR-detectable 
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effects on water molecules that can be detected using chemical exchange 
saturation transfer methods (CEST) [19, 20], this principle can be exploited to 
directly detect the scaffold material. For instance, addition of gelatin to HA 
hydrogels can be used to detect the HA implant using diamagnetic CEST 
(diaCEST) [21]. Preferably no additional molecules are required to afford 
detection. Hydrogels derived from ECM that is manufactured by decellularization 
of a source tissue retain most molecules and hence potentially provide a 
multitude of molecules that can exert CEST effects. We here described the in 
vitro characterization of CEST effects induced by ECM in its liquid form and upon 
gelation, as well as their in vivo detection in a rat model of stroke with histological 
validation. 
 
 
2. Methods 
2.1. Extracellular matrix hydrogel 
ECM was derived from the basement membrane and tunica propria of porcine 
urinary bladder (Tissue Source, Lafayette, IN). A mechanical delamination of the 
luminal epithelium and subjacent layers was followed by decellularization. 
Decellularization of the tissue was accomplished by 0.1% peracetic acid in 4% 
ethanol (v/v; 120 min; 300 rpm) and agitation prior to washing out of cellular 
components with PBS and deionized water rinses. Confirmation of 
decellularization was achieved using a series of measures (Hematoxylin & Eosin, 
4’,6-diamidino-2-phenylindole (DAPI) staining, agarose gel electrophoresis, and 
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 7 
measurement of DNA content). This material was lyophilized, comminuted, and 
solubilized with pepsin (1 mg/mL) in 0.01 N HCl prior to neutralization with 0.1 N 
NaOH. The final product was an injectable liquid at room temperature (21 °C) 
that formed a hydrogel at concentration >3 mg/mL at brain temperature (37 °C) 
[8]. Concentrations of 0 (PBS only), 2, 4, 6, and 8 mg/mL were used for in vitro 
experiments, whereas only 8 mg/mL was used for in vivo experiments. 
MatristemTM (ACell Inc. Columbia, MD) was used for comparison of a 
commercially available UBM-ECM product. 
 
2.2. In vitro CEST imaging 
Hardware: MR Images were acquired on a 9.4 T horizontal bore system 
interfaced to a DirectDrive 2 console (Agilent, Santa Clara, CA, USA). For 
phantom studies, a volume coil with an internal diameter of 38 mm was used 
(Agilent, Santa Clara, CA, USA). For in vivo studies, a custom made volumetric 
birdcage quadrature coil (Virtumed LLC) achieving a radiofrequency (RF) power 
input of up to 55 μT / 5 s with an internal diameter of 36 mm and effective length 
of 25 mm was used.  
CEST imaging: All in vitro imaging was carried out at room temperature (apart 
from the varied-temperature experiments). Two sets of imaging parameters were 
adopted. CEST images were acquired by 2-shot spin-echo echo planar imaging 
(EPI) with FOV = 50 mm x 25 mm, matrix 128 x 64, TR = 10 s, and TE = 7.4 ms. 
A B1 map was first acquired to calibrate the transmit power for the CEST studies 
and evaluate the B0 homogeneity. Because the spatial variation of B1 is <15% for 
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 8 
all of our phantoms, no correction of the B1 inhomogeneity was applied. The 
CEST sequence was used to acquire Z-spectra between -8 to +8 with 43 interval 
offsets. The interval was chosen to be uneven since the chemical shift of most 
endogenous labile protons from water was less than 4 ppm. Thus the interval 
was 0.2 ppm from -1 to 1 ppm, 0.25 ppm from 1 ppm to 4 ppm and -1 ppm to -4 
ppm, and 1 ppm from 4 to 8 ppm and -4 to -8 ppm. Additionally, images were 
acquired at offsets of 300 ppm for normalization. A B0 map was obtained by 
using the water saturation shift referencing (WASSR) scheme [22], where a low 
power saturation (10 Hz) pulse was applied for 1 s, with 31 offset values ranging 
from -0.3 to 0.3 ppm in 0.02 ppm steps. In data sets where a significant B0 
inhomogeneity (B0 variation >10Hz) was detected, the RF offset of images were 
interpolated to a 1 Hz interval on a pixel-by-pixel basis and shifted according to 
the B0 map. Optimization of the saturation power was explored using an array 
(65, 220, 420, 750 Hz) of saturation frequencies. For saturation power of d420 
Hz, the saturation duration was 5 s. For the highest power of 750 Hz, the direct 
water saturation (DWS) became significant even at 2-3 ppm. To minimize DWS 
and RF heating, an off-resonance spin-lock sequence was used [23, 24], and the 
irradiation duration was reduced to 3 seconds. Data were processed in MATLAB 
to generate magnetization transfer ratio asymmetries (MTRasym), which were 
calculated from [25] 
),300(/)]()([)( ppmSSSMTR satsatsatasym :: :   
where Ssat(:) is the signal intensity with a saturation pulse at frequency offset of 
:. All subsequent experiments used an acquisition frequency of 220 Hz. 
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2.3. Temperature and pH effects on CEST signal 
Chemical exchange is highly sensitive to temperature and pH. To probe the 
effects of temperature and pH on the CEST signal, both variables were arrayed 
and CEST images were acquired. For this, 8 mg/mL ECM hydrogel samples 
were created where pH was neutralized (pH 7). To adjust pH, Sodium hydroxide 
or Hydrochloric acid were added to the hydrogels and pH was confirmed with a 
pH spear (Eutech Instruments). ECM samples with an array of pH (5.5, 6.0, 6.5, 
7.0) in 2 mL Eppendorfs were placed in 4% Agar holders. A temperature probe 
was placed into the Agar. These samples were placed into the MR scanner and 
temperature was controlled by circulating hot air to reach room temperature (21 
°C), body temperature (37 °C) and an intermediate transition temperature (30 
°C). 
 
2.4. Liquid phase versus hydrogel ECM 
In order to assess whether the gelation state of the ECM affects its detection, 
both liquid and gelled samples were imaged. 8 mg/mL ECM was prepared, and 
incubated for 40 min at 37 °C to allow gelation. Meanwhile, fresh ECM was 
prepared (with no gelation step) and maintained on ice until imaging. Samples 
were imaged at 21 °C.  
 
2.5. Preparation of individual ECM components  
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 10 
To ascertain which ECM components are contributing to the CEST signal, 
purified proteins (Table 1) and artificial cerebro-spinal fluid (aCSF, Harvard 
Apparatus, 597316) were imaged separately for comparison with the ECM-
derived signal. Solutions were made up in PBS and samples were imaged at 21 
°C. 
 
2.6. Middle cerebral artery occlusion – a rat model of stroke 
All animal procedures complied with the US Animals Welfare Act (2010) and 
were approved by the University of Pittsburgh Institutional Animal Care and Use 
Committee (IACUC). As previously described, 14 male Sprague-Dawley rats 
(260±15 g, Taconic Labs, USA) underwent transient intraluminal right middle 
cerebral artery (MCA) occlusion, a rat model of stroke [26]. For this, under 
isoflurane (4% induction, 1% maintenance in 30% O2) anesthesia, a 5-0 silicon 
rubber-coated monofilament (503556PK10, Doccol, USA) was advanced to the 
ostium of the MCA in the circle of Willis and the MCA was occluded for 70 
minutes prior to reperfusion. After recovery from anesthesia, animals were 
assessed for forelimb flexion and contralateral circling with daily post-operative 
care and neurological assessment until they recovered pre-operative weight [26, 
27]. 
 
2.7. In vivo CEST imaging  
Rats were anesthetized with isoflurane (4% induction, 1% maintenance). T2-
weighted images were acquired using a Fast Spin Echo Multi Slice sequence to 
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 11 
determine the location of lesion and to select the slices for CEST imaging (TR = 
8 s, TE = 53 ms, number of segments = 16, number of averages = 4, 30 x 30 mm 
FOV, 128 x 128 matrix, 42 slices with 0.5 mm slice thickness). Tissue volume 
loss was based on a hyperintense signal on T2-weighted images that were 
thresholded at 1 standard deviation above the mean of a rectangular region of 
interest (ROI) in the contralateral hemisphere, encompassing striatum, corpus 
callosum and neocortex [28]. Rats with lesion volume <40 mm3 (i.e. 40 μl) were 
excluded [8]. T2-weighted images also served as anatomical reference for CEST 
image overlays. For a proof-of-principle of detection, 3 MCAO rats with ECM 
hydrogel injection (see below) underwent CEST imaging 24 hours after 
implantation. To evaluate the time-dependence of the CEST effect, 3 groups of 
rats (MCAo only, n=3; MCAo+PBS, n=3; MCAo+ECM hydrogel, n=4) were 
imaged 4 times; namely, pre-injection, 1, 3 and 7 days after the post-injection. 
 For CEST imaging, B1 and B0 maps were first obtained, similar to phantom 
studies. To acquire the Z-spectrum, a saturation pulse with a power of 220 Hz 
and a duration of 2 s was applied. Images were acquired immediately after the 
saturation with a 2-shot spin-echo EPI. 43 different RF offsets were acquired 
from -8 to +8 ppm, as for the phantom studies. The parameters for imaging were: 
TR = 6.5 s; TE = 7.6 ms; FOV = 30 x 30 mm; matrix size = 96 x 96; 5 slices with 
1 mm thickness. CEST images were thresholded to 3 standard deviations of the 
contralateral hemisphere to visualize only signal that is above the noise threshold 
and the baseline CEST signal (Supplementary Figure 1). 
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 12 
Image Registration: The baseline MR scan of a single case was chosen as a 
reference and all structural MR images were rigidly (i.e. with 6 degrees of 
freedom) registered to this reference using a previously described registration 
method [29] based on the FLIRT software [30]. For each rat at each time-point, a 
composite transformation was obtained by combining the transformation of each 
diaCEST image onto the corresponding MR image (derived from scanner 
positional information) with the transformation of the MR image onto the 
reference scan. Thus, all structural MR scans and all diaCEST images were 
rigidly registered into the same reference space. For accurate serial analysis, the 
post-treatment MR scan of each rat was further registered directly to the pre-
treatment scan and the same transformation was applied to the associated 
diaCEST images.  
Post-Processing: Mean structural and diaCEST images were computed for each 
group (MCAO only, PBS and ECM) in the reference space. Change in diaCEST 
signal in each rat over time was obtained by subtracting the pre-treatment image 
from the corresponding post-treatment images. To establish a suitable 
physiological noise level in the CEST images, a region of interest was drawn 
spanning the contra-lateral hemisphere in the reference MR image. This region 
was used to obtain the mean and standard deviation signal in each registered 
diaCEST image and in each diaCEST serial subtraction image. A threshold 
range of mean ± 3 std. dev. was used to exclude all signal within the range 
typically seen in the contra-lateral hemisphere (Supplementary Figure 2). 
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2.8. Implantation of ECM hydrogel 
Fourteen days post-MCAo, rats underwent the implantation procedure by 
placement into a stereotactic frame (Kopf, USA) under isoflurane anesthesia 
(1.5% in 30% O2) prior to drilling of burr holes at the appropriate coordinates for 
injection and drainage using a frame-mounted drill [8]. The injection volume of 
biomaterial was equivalent to the lesion volume, as determined by the 
hyperintense volume range on MR images (40-180 μL). The ECM was taken-up 
into a 250 μl Hamilton syringe with a 24 G beveled tip metal needle (Hamilton) 
mounted on the frame. The syringe/needle was advanced to the appropriate 
coordinates for biomaterial injection, whereas a 24 G cannula was placed in 
position to drain ECF. Injection of ECM hydrogel (8 mg/mL) was controlled using 
a frame mounted injection pump (World Precision Instruments, USA) at a 
constant speed of 10 μL/min. After the injection was complete, the needle and 
cannula were left in place for 5 minutes before being slowly removed from the 
brain with burr holes being filled with bone wax (Fisher) prior to suturing. LX4 
(Ferndale, containing 4% Lidocaine) was topically applied as an analgesic, and 
Buprenex (0.05 mg/kg) was administered sub-cutaneously. 
 
2.9. Immunohistochemistry 
To analyze the distribution of the ECM hydrogel within the lesion cavity, rats were 
transcardially perfused with 0.9% saline followed by 4% paraformaldehyde (in 0.2 
M PBS) 1 or 7 days post-implantation to fix brain tissue prior to its removal from 
the skull. Brains were post-fixed in 4% paraformaldehyde for 24 h prior to being 
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 14 
cryopreserved in 30% sucrose with sodium azide (Sigma) at 4° C. Histological 
sections (50 μm thickness) were cut on a cryostat (Leica) directly onto 
microscopic slides. Brain sections were washed 3 x 5 minutes with 0.01 M PBS, 
followed by one hour in blocking solution (PBS + 0.05% Triton X-100 + 10% 
Normal Goat Serum, NGS, Vector). Primary antibodies were then applied, 
consisting of rabbit anti-collagen I (1:250, Abcam, AB34710), mouse anti-
fibronectin (1:150, Abcam, AB6328), mouse anti-chondroitin sulfate (1:200, 
Abcam, AB11570) and a chicken anti-Glial Fibrillary Acid Protein (GFAP, 1:3000, 
Abcam, AB4674) antibody diluted in blocking solution (0.05% Triton X-100, 10% 
NGS in PBS). Sections were incubated at 4 °C overnight. After rinsing of the 
primary antibodies (3x10 min PBS), appropriate secondary Alexa Fluor 488 and 
555 antibodies (Life Technologies) were applied for 1 hour. Secondary antibodies 
were washed off and sections were incubated with Hoechst (1 μg/mL, Sigma, 
14533) for 10-15 min prior to 3 x 5 min washes in PBS and being coverslipped 
with Vectashield for fluorescence (Vector Laboratories). Visualization of 
antibodies was performed on a fluorescence microscope (M2 Axioimager, Zeiss) 
with a monochrome camera driven by Stereo Investigator image capture 
software (MBF Bioscience).  
 
 
3. Results  
3.1. In vitro CEST characteristics of extracellular matrix hydrogel 
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Extracellular matrix (ECM) contains a variety of molecules that can potentially 
affect chemical exchange saturation transfer (CEST) with water. To define an 
acquisition paradigm that will afford a robust detection, an array of frequencies 
was applied to record the chemical exchange saturation transfer (SSat/S0) of ECM 
hydrogel (8 mg/mL) over a relevant range of radiofrequency (RF) offsets (Figure 
1A). Blips in the spectra are evident indicating specific exchange sites, especially 
around +3.6 ppm (65 Hz), but also a broader underlying asymmetry between the 
negative and positive offset at higher frequencies. Indeed, magnetization transfer 
asymmetry (MTRasym), which was obtained by subtracting the positive from the 
negative offset, reveals effect sizes of up to 8.5% at 2.8 ppm with 750 Hz (Figure 
1B). Indeed, the most significant asymmetry was apparent with a frequency of 
750 Hz. However, the smoothness of the curve did not clearly reveal a specific 
exchange site. In contrast, the lower frequencies of 220 Hz and 65 Hz reveal 
specific exchange sites at 3.6 ppm, 2.8 ppm, as well as at 1.8 ppm. The 65 Hz 
frequency provides the sharpest definition of these sites, but the effect size is 
markedly reduced compared to the 4.3% (3.6 ppm) and 6.5% (1.8 ppm) MTRasym 
at 220 Hz. A 220 Hz acquisition hence provides specific exchange site, as well 
as marked contrast for the ECM hydrogel. Images of the MTRasym further indicate 
a robust visualization of the ECM hydrogel using 220 Hz compared to 65 Hz 
(Figure 1C). Although 420 Hz and 750 Hz also afforded a robust detection with a 
more significant asymmetry at all sampled frequencies, these effects are less 
specific, which renders them more susceptible to unspecific MTR effects that 
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could compromise a specific detection of ECM hydrogels in vivo. All subsequent 
experiments therefore used the 220 Hz frequency for acquisition. 
 
3.2. Magnitude of ECM CEST signal is affected by temperature 
As the CEST signal is affected by both temperature and pH (due to changes in 
the chemical exchange rate), both were arrayed to establish their effect on 
detection of the ECM hydrogel (8 mg/mL). Indeed, the temperature of the ECM 
will increase from room temperature (21 °C) to body temperature (37 °C) upon 
implantation and allow gelation of the material. Although pH of the ECM hydrogel 
is neutral upon injection, the infarcted area has a low pH and could reduce pH in 
the injected ECM. There was an overall effect of temperature, which increased 
MTRasym at 1.8 ppm by ~42%, from 7.3% at 21 °C to 10.4% at 37 °C (pH 7.0) 
(Figure 2A). Since CEST signal is nearly proportional to the water T1, this 
increase is likely caused by an increase of T1, which increased from 2.8 s at 
room temperature to about 4.0 s at 37 °C. The same pattern was observed for all 
pH values, but notable differences in the z spectra were also apparent. For 
instance, at 21 °C, the MTRasym at 2.8 ppm was much more pronounced for low 
pH values, but this difference gradually eroded with an increase in temperature. 
Furthermore at 37 °C, pH 7 was increased from the other pH values at 1.8 ppm, 
but only by ~16%. Temperature therefore increased the MTRasym overall, which is 
advantageous for detection in the brain, whereas the effect of pH was negligible. 
 
3.3. ECM concentration affects magnitude of CEST signal 
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AS ECM is injected into the brain at 21 °C, it transitions from a liquid phase to a 
hydrogel state at 37 °C by cross-linking of proteins, such as collagen I. The 
cross-linking and the associated rheological changes are also dependent on the 
concentration of the ECM. The physical characteristics of the ECM therefore 
change in a concentration-dependent fashion and could affect detection using 
diaCEST. In the liquid phase, a robust detection of the ECM is observed at 8 
mg/mL with a dose-dependent decrease in signal down to 2 mg/mL (Figure 2B). 
A 0 mg/mL (PBS only) condition did not produce any detectable MTRasym. 
Formation of a hydrogel (i.e. bringing the ECM to 37 °C) also produced a dose-
dependent signal (Figure 2C). However, separation between 2 and 4 mg/mL was 
less clear, potentially due to a lack of gelation of 2 mg/mL. The 4 mg/mL hydrogel 
condition hence produces an MTRasym that is akin to the 2mg/mL liquid MTRasym. 
It is noteworthy that these MTRasym properties of ECM hydrogel are also evident 
in the commercially available ECM product Matristem (Supplementary Figure 3). 
A potential confound of the dose-dependent ECM MTRasym is pepsin, which is 
also added during the ECM preparation in a dose-dependent fashion. However, 
different doses of pepsin did not produce an MTRasym that could confound the 
ECM detection (Figure 2D). 
 
3.4. Chondroitin sulfate and fibronectin are prominent components of ECM 
hydrogel CEST signal 
As the ECM hydrogel is an agglomeration of different molecules present in 
tissue, it is unclear what specific molecules contribute to the MTRasym. Individual 
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components were hence prepared to evaluate their MTRasym for comparison with 
the ECM-induced MTRasym. Some ECM molecules (collagen I, heparin sulfate) 
produced negligible (<1%) MTRasym, whereas others (collagen IV, hyaluronic 
acid, laminin, vitronectin) induced minor effects of 1-2.5% (Figure 3A). In 
contrast, chondroitin sulfate and fibronectin produced significant MTRasym of 4-7% 
at 1.8 ppm. It is intriguing to observe that these two molecules produce an 
overlapping MTRasym very similar to ECM, with a combination of both replicating 
the overall shape of an ECM hydrogel-induced MTRasym (Figure 3B).  
As the application of ECM hydrogel will require injection into the fluid-filled 
cavity caused by a stroke, another factor potentially affecting the specificity of 
detection is the presence of extracellular or cerebrospinal fluid (CSF). Artificial 
CSF produced a 3.5% MTRasym at 1 ppm and 1.7% at 1.8 ppm (Figure 3A), which 
is very similar to that observed from HA, but distinct from ECM. ECM hydrogel 
can therefore be specifically detected in contrast to potentially confounding 
variables (PBS, Pepsin, CSF) and produce a robust dose-dependent MTRasym. 
 
3.5. In vivo detection of ECM hydrogel distribution in a rat model of stroke 
Upon ECM hydrogel implantation into the cavity 14 days post-stroke, a CEST 
signal covering the lesion was evident 24 hours post-injection in all animals 
(Figure 4A). The CEST signal highlighted the anterior-posterior distribution of 
ECM and its macroscopic comparison to histology further confirmed that the 
signal corresponded to the area filled with ECM hydrogel (Figure 4B). However, a 
more detailed comparison between the CEST and histology image revealed 
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subtle differences that indicate that some of the CEST signal is not specific to the 
injected material (Figure 4C). Specifically, damaged peri-infarct tissue, as well as 
areas with a T2 hyperintense signal, also overlap with the CEST signal, but do 
not contain ECM hydrogel as revealed by collagen I staining, hence suggesting 
that some endogenous molecules might be upregulated in these areas and 
account for these areas of discrepancy. Nevertheless, the overall distribution of 
the ECM hydrogel and CEST signal is comparable and reveals, for instance, 
material that unexpectedly leaked into the lateral ventral (Figure 4D). 
 
3.6. In vivo specificity and evolution of ECM hydrogel CEST signal  
The presence of a baseline CEST signal, as well as its increase in damaged 
tissue, question the specificity of the approach for ECM hydrogel. Indeed, in the 
contralateral undamaged hemisphere, a weak <5% CEST signal at 1.8 ppm can 
be found (Figure 5). This CEST signal is mainly from the intracellular proteins 
and metabolites, but the intensity is relatively low due to the short tissue T2 (~40 
ms at 9.4 T) and the large direct water saturation effect. A slightly larger signal of 
up to 5% is also present within the lateral ventricles, whereas the signal within 
the lesion cavity is significantly increased compared to undamaged brain and 
ventricles to 8.6% MTRasym. Note the larger CEST signal in the lesion cavity does 
not necessarily indicate a higher protein/ECM concentration. Besides the 
chemical exchange mediated relaxation, the CEST signal is also affected by 
other relaxation effects, such as T1, T2 and direct water saturation. These 
relaxation effects are expected to be smaller in the lesion cavity due to its higher 
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water content. Nevertheless, implantation of ECM hydrogel within this same area 
dramatically increased the signal to >20% MTRasym. It is hence plausible that 
endogenous ECM molecules produced a weak signal in the lesion cavity, but that 
the injection of ECM hydrogel dramatically increased this signal to a level that is 
very distinct in its magnitude from the endogenous MTRasym.. 
 To selectively visualize the distribution of the ECM hydrogel, it is therefore 
necessary to account for this endogenous signal. This can be achieved by 
acquiring a pre-implantation baseline image that is subtracted from post-
implantation images. Using this post-processing of the CEST images, the 
distribution of ECM hydrogel can be specifically and selectively visualized at 
different time points (Figure 6). Consistently the injection of ECM hydrogel in 4 
animals lead to an increased signal in the lesion cavity by 1 day post-implant. In 
two animals with a large well-defined T2-weighted hyperintense lesion cavity, a 
very robust and cohesive signal increase can be observed with >20% MTRasym. 
In one animal (rat 3), a more irregular lesion cavity also showed a clear increase 
in MTRasym in the cavity, but patches adjacent to the main area were evident. In 
rat 4, the detection of the ECM hydrogel was less robust. In all animals, the 
signal due to the ECM hydrogel dramatically reduced within 3 days post-
implantation to reach baseline levels and below baseline by day 7. These 
observations were also supported by MTRasym plots of the lesion cavity at each 
time point. Nevertheless, histology at day 7 revealed a robust presence of ECM 
hydrogel in the lesion cavity in all animals. 
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3.7. Group comparison of CEST signal with control conditions  
To afford a group comparison of the CEST signal due to the ECM hydrogel 
injection, animals were coregistered and mean images were created for a MCAo 
only, a vehicle (PBS) injection, as well as an ECM injection condition (Figure 7). 
In the MCAO only condition, no change of the CEST signal in the stroke area 
was evident over 7 days. A vehicle injection revealed a slight increase in the 
CEST signal in damaged tissue 1 day post-injection, but upon further inspection 
this was only evident in 1 animal out of 4. This CEST signal is mainly from the 
intracellular proteins and metabolites, but the intensity is relatively low due to the 
short tissue T2 (~40 ms at 9.4 T) and the large direct water saturation effect. A 
slightly larger signal of up to 5% is also present within the lateral ventricles, 
whereas the signal within the lesion cavity is significantly increased compared to 
undamaged brain and ventricles to 8.6% MTRasym. Note the larger CEST signal in 
the lesion cavity does not necessarily indicate a higher protein/ECM 
concentration. Besides the chemical exchange mediated relaxation, CEST signal 
is also affected by other relaxation effects such as T1, T2 and direct water 
saturation, and these relaxation effects are expected to be smaller in lesion 
cavity due to its higher water content. Nevertheless, implantation of ECM 
hydrogel within this same area dramatically increased the signal to >20% 
MTRasym. It is hence plausible that endogenous ECM molecules produced a 
weak signal in the lesion cavity, but that the injection of ECM hydrogel 
dramatically increased this signal to a level that is very distinct in its magnitude 
from the endogenous MTRasym. 
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 To selectively visualize the distribution of the ECM hydrogel, it is therefore 
necessary to account for this endogenous signal. This can be achieved by 
acquiring a pre-implantation baseline image that is subtracted from post-
implantation images. Using this post-processing of the CEST images, the 
distribution of ECM hydrogel can be specifically and selectively visualized at 
different time points (Figure 6). Consistently the injection of ECM hydrogel in 4 
animals lead to an increased signal in the lesion cavity by 1 day post-implant. In 
two animals with a large well-defined T2-weighted hyperintense lesion cavity, a 
very robust and cohesive signal increase can be observed with >20% MTRasym. 
In one animal (rat 3), a more irregular lesion cavity also showed a clear increase 
in MTRasym in the cavity, but patches adjacent to the main area were evident. In 
rat 4, the detection of the ECM hydrogel was less robust. In all animals, the 
signal due to the ECM hydrogel dramatically reduced within 3 days to reach 
baseline levels, and dropped to a level below the baseline at day 7. These 
observations were also supported by MTRasym plots of the lesion cavity at each 
time point. Nevertheless, histology at day 7 revealed a robust presence of ECM 
hydrogel in the lesion cavity in all animals. 
 
3.7. Group comparison of CEST signal with control conditions  
To afford a group comparison of the CEST signal due to the ECM hydrogel 
injection, animals were coregistered and mean images were created for a MCAo 
only, a vehicle (PBS) injection, as well as an ECM injection condition (Figure 7). 
In the MCAO only condition, no change of the CEST signal in the stroke area 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 23 
was evident. A vehicle injection revealed a slight increase in the CEST signal in 
damaged tissue 1 day post-injection, but upon further inspection this was only 
evident in 1 animal out of 4. While the averaged MTRasym spectra showed little 
change at day 1 after the PBS injection (yellow vs. red, Fig. 7B), at day 3 and 7 
the spectra became much lower. At 1.8 ppm, the MTRasym is 11.1%, 11.3%, 
7.3%, and 6.4% for preinjection and day 1, 3, and 7 after PBS injection, 
respectively. Compared to the case without injection, the significant drop of 
MTRasym over time after the PBS injection indicated some physiological change 
caused by (or in response to) the injection, but the source is still unclear and 
requires further investigation. In contrast, in the ECM group a robust increase in 
the CEST signal was observed throughout the hyperintensity delineating the 
lesion cavity on the T2-weighted MR image. The signal evident at 1 day post-
implantation in ECM hydrogel implanted animals is hence selective to this 
material and reveals its in vivo distribution. However, by 3 days post-implantation 
the area of distribution was much reduced. By 7 days, no CEST signal above 
baseline could be detected. These visual representations are further supported 
by direct measurements of the MTRasym in the lesion area (Figure7B). A clear 
peak of the CEST signal is evident at 1.8 ppm with >20% MTRasym on day 1 after 
ECM injection. In contrast to the CEST image, at 7 days post-implantation there 
was still a robust histological evidence of ECM hydrogel present within ECM 
injected animals, whereas there was no material was present within MCAo only 
or PBS injected animals (Figure 7C). Nevertheless, there was evidence in 1 PBS 
animal that there was an upregulation of collagen I in a peri-infarct area, which 
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indicates an endogenous response to the injection of vehicle that is likely to 
upregulate ECM molecules to a level that is distinct from its pre-implantation 
state and sufficient to induce a small increase in CEST signal. However, this 
increase was evident in the other animals in this group indicating that an injection 
of a large volume of PBS inside damaged tissue, rather than the cavity, in this 
one animal might underlie these histological and imaging observations. 
 
3.8. Time course comparison of CEST signal and ECM molecules in infarct 
and hydrogel 
A comparison of the time course of the CEST signal with histology indicates that 
in MCAo only animals, the CEST signal is almost exclusively confined to the T2-
hyperintensity of the lesion corresponding histologically to the cavity, rather than 
surrounding damaged tissue, as indicated by GFAP reactivity of glia limitans 
(Figure 8A). Nevertheless, collagen I, chondroitin sulfate and fibronectin are all 
upregulated in this peri-infarct area compared to intact tissue. After ECM 
hydrogel injection, the cavity is filled with ECM hydrogel, as indicated by collagen 
I staining, corresponding to the area of increased CEST contrast. Still, some 
CEST signal is evident in damaged cortical regions, where no ECM hydrogel is 
evident. Chondroitin sulfate and fibronectin are also highly present within the 
ECM hydrogel hence providing a larger area of coverage, as well as a greater 
abundance of the molecules compared to the MCAo only condition (Figure 8B). 
By 7 days, the area and magnitude of the CEST signal is reduced, but the area 
covered by the ECM hydrogel still corresponds to the lesion cavity, hence 
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indicating a mismatch between the CEST signal and the ECM hydrogel due to 
the CEST signal returning to its baseline state. There is also a significant 
decrease in fibronectin within the ECM hydrogel and to a lesser degree a 
decrease in chondroitin sulfate that highlights the contribution of fibronectin and 
chondroitin sulfate to the specific and selective imaging of ECM after injection. 
The loss of these molecules is likely due to constructive remodelling, which 
eventually leads to a biodegradation of the ECM hydrogel. 
 
 
4. Discussion 
The use of extracellular matrix (ECM) as an inductive scaffolding material in 
regenerative medicine is finding wide-ranging applications [7], yet little advances 
have been achieved in monitoring the distribution and degradation of these 
bioscaffolds using non-invasive imaging [18]. Herein, we here demonstrate that 
ECM hydrogel has specific diamagnetic chemical exchange saturation transfer 
(diaCEST) properties that can be exploited to visualize its distribution acutely 
after implantation into a stroke cavity in the brain. Chondroitin sulfate and 
fibronectin are likely to be the main source of this effect, with the decrease of 
these molecules in the ECM hydrogel resulting in a return to the baseline CEST 
signal. Chondroitin sulfate and fibronectin within ECM hydrogel therefore provide 
specificity to the imaging approach, but their level of abundance conveys the 
selectivity to visualize the injected bioscaffold against the ECM background in the 
brain. 
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4.1. Specificity of ECM hydrogel detection by CEST imaging 
The ECM is a collection of molecules that forms tissue out of cells [31]. Upon 
decellularization, these ECM molecules are retained and can be used for 
bioscaffolding [7, 32]. Non-invasive imaging of ECM molecules has mainly 
focussed on glycosaminoglycans (GAGs) due to their presence in intervertebrate 
discs and the clinical need to improve our ability to visualize its degradation. The 
assessment of GAG content can be achieved using CEST imaging [19, 33]. 
Implantation of a biomimetic ECM to promote cartilage regeneration indicated 
that these materials produce MRI characteristics similar to that of the native 
tissue [34, 35], but no gagCEST was performed to visualize the scaffold using its 
biochemical characteristics. Importantly four classes of GAGs can be recognized: 
heparin sulphate; chondroitin sulphate; keratin sulfate; and hyaluronic acid [36]. 
Indeed, chondroitin sulfate and hyaluronic acid are known to be present at a high 
concentration within the urinary bladder-derived ECM and detectable using 
immunohistochemistry against the lower abundance present within the native 
brain [8]. Our in vitro studies here showed that CS and HA induced CEST effects 
and potential for CEST imaging. Especially at 1.8 ppm, CS showed a marked 
effect with a 7% MTRasym effect compared to a 2.5% effect of HA. In contrast, 
collagen I which is highly present with ECM from urinary bladder exerted a 
negligible ~1% MTRasym. Still, most ECM molecules tested here exhibited small 
effects between 0.2-2 ppm. Only CS and fibronectin exhibited wider chemical 
shifts. Indeed, chondroitin sulfate and fibronectin combined produce a MTRasym 
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generally resembling the ECM profile, suggesting that the other molecules tested 
here exert a minor contribution to the CEST detection of ECM hydrogel. UBM-
ECM-specific CEST imaging is hence feasible based on the MTRasym generated 
by CS and fibronectin. In contrast to ECM, the use of particular ECM molecules, 
such as HA, and its combination with other molecules potentially provides a 
mean to image those molecules more specifically in the absence of these in the 
native tissue [21]. However, a separation of individual molecules’ signals will be 
challenging in a naturally mixed preparation, such as ECM, as there is a 
significant overlap between the MTRasym of these molecules. 
 The interaction and complexing of molecules in a mixed environment, 
such as the ECM, is also likely to influence the CEST effects that the individual 
molecules exert. Indeed, protein composition is known to affect biodegradation 
and rheological properties, which can affect MR parameters, such as T2 and 
diffusion [12, 37]. It was also evident here that detection of the CEST signal was 
influenced by the phase of the ECM (i.e. liquid versus cross-linked into a 
hydrogel). An overall decrease of the CEST signal was apparent. Importantly, at 
lower concentration with incomplete gelation [8], little distinction was, for 
instance, observed between 2 and 4 mg/mL in the hydrogel preparation. Still, a 
robust dose-dependence was evident indicating a linear relationship between 
concentrations >3 mg/mL and the CEST signal. Indeed, changes in the 
rheological properties due to cross-linking are likely to influence T2 signal, as 
well as NMR properties [38]. Although gagCEST is highly correlated with the T2 
signal in native tissue [39], cross-linking of a hydrogel will not only influence 
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water content of the material leading to a decrease in T2 signal, but will also 
affect its NMR properties [40]. A transition here from the liquid phase to the 
hydrogel state resulted in an overall reduction of the MTRasym. Still, an effect size 
of ~6% in vitro indicated potential for in situ visualization. Encouragingly, pH did 
not significantly affect the ECM hydrogel signal and the MTRasym was actually 
improved at physiological normothermia (i.e. 37 °C). A specific dose-dependent 
CEST signal of ECM hydrogel can hence be achieved that is marginally affected 
by pH and temperature.  
 
4.2. Selective in vivo monitoring of hydrogel distribution and degradation 
Injection of ECM hydrogel at 8 mg/mL afforded the detection of a specific CEST 
signal at 1.8 ppm that covered the lesion cavity. However, noise and background 
ECM signal required the application of a threshold to selectively visualize the 
signal increase. This signal was macroscopically corroborated by 
immunohistochemistry for the ECM hydrogel based on collagen I staining and 
was consistent with previous experiments [8]. However, a more detailed 
investigation of the correspondance between the CEST signal and the 
histological distribution of ECM hydrogel revealed small patches of mismatch, 
suggesting that damaged host tissue also produces a CEST signal at 1.8 ppm. 
Indeed, it is known that a variety of ECM molecules (e.g. chondroitin sulphate; 
fibronectin; laminin; collagen IV; hyaluronic acid) are upregulated in the peri-
infarct area [41-44], as well as after intracerebral injection [45], thus 
compounding the “specific” CEST signal at 1.8 ppm. To distinguish this 
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endogenous upregulation of the CEST signal in the stroke brain from the ECM 
hydrogel injected signal, acquisition of a baseline pre-implantation image allowed 
us to subtract this endogenous baseline signal from the post-implant CEST to 
reveal changes due to the injected material. This produced a selective 
visualization of the ECM hydrogel distribution at day 1, but also indicated that an 
additional upregulation of endogenous ECM molecules can be caused by 
injection damage to the peri-infarct region. These results hence indicate that 
ECM hydrogel can be detected selectively, but that interpretation of any CEST 
changes needs to include a careful consideration of alternative endogenous 
sources of contrast. 
Considering the microenvironment inside the lesion cavity, semi-solid 
macromolecular magnetization transfer (MT), as well as water proton saturation 
(spillover), provide competing signals influencing CEST imaging within a stroke 
lesion [46, 47]. Nevertheless, the magnitude of increase in MTRasym due to the 
ECM injection against the stroke environment is ~10% providing a robust 
detection of distribution within the lesion, but also erroneous hydrogel 
localization, for instance in the ventricle. This demonstrates the usefulness of this 
approach to map the delivery and initial distribution of the ECM hydrogel within 
the stroke lesion environment, akin to our previous report using 
immunohistochemical methods to detect ECM hydrogel [8]. Still, the degradation 
of the material reduced the abundance of ECM molecules and within 3 days 
mostly returned to baseline. Remodeling of the ECM lead to a decrease in 
fibronectin and chondroitin sulphate, which is likely to account for the decrease in 
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CEST signal. However, ECM material here resulted in a fairly broad CEST effect 
with specific peaks at 1.8 and 3.6 ppm, which is more weighted by chondroitin 
sulfate and fibronectin. While the 3.6 ppm signal is likely due to the amide-water 
proton transfer effects [25], the exact source of the 1.8 ppm signal is not clear. 
The signal reaches maximum with a relatively high power of 220Hz, suggesting a 
fast chemical exchange rate. Thus, it may arise from hydroxyl protons, which 
have a chemical shift of 1-3 ppm from water [48], or amine groups from the side 
chain of mobile proteins [49, 50]. Interestingly, others reported similar CEST 
effects (also at 1.8 and 3.6 ppm) using hyaluronic acid hydrogels supplemented 
with gelatin [21]. In order to quantify the degradation of the biomaterial more 
accurately, implementation of imaging approaches geared towards measuring 
the macromolecular tissue volume might be needed [51], whereas monitoring the 
degradation of specific ECM molecules would require their tethering to contrast 
agents, such as gadolinium [14]. 
 
5. Conclusions 
dia-CEST imaging is an exciting new imaging technique to non-invasively 
visualize hydrogels of different constituents. Herein, we demonstrated that it 
affords the selective visualization of an ECM hydrogel injected into a stroke-
cavity by targeting a specific frequency at which the “contrast” is tuned towards 
chondroitin sulfate and fibronectin. Although the imaging is robust towards 
changes in pH and temperature, other molecules can exert similar effects as the 
CEST signal is not directly detecting ECM molecules, but is sensitive towards 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 31 
their labile proton content, and both hydroxyl and amine signals may contribute in 
this frequency range. A further consideration is that endogenous ECM also exert 
a minor CEST effect which is upregulated in the area of infarction, hence 
requiring subtraction of a baseline CEST imaging to provide a truly selective 
imaging of the distribution of ECM hydrogel distribution. Certainly, specific and 
selective monitoring of the ECM hydrogel and its degradation requires further 
development of the imaging approach, but also advances in tuning material 
properties that can improve their detection against host background.  
 
 
Acknowledgements 
This study was funded by a seed grant from the Department of Health of the 
Commonwealth of Pennsylvania (4100068505) and the National Institute for 
Neurological Disease and Stroke (R01NS08226). The authors thank Dr Wen Ling 
for acquiring pilot data, Ms Madeline Gerwig for sectioning the brains, and 
Brendon Wahlberg for post-op care of MCAO animals. 
 
Author Contributions 
JT set-up, acquired and developed the post-processing of dia-CEST images. 
FJN prepared all samples, performed MCAo surgery and ECM implantation and 
perfused animals. WC performed co-registration, group mapping and statistical 
image comparisons. HG performed immunohistochemistry and acquired 
histology images. SFB provided the ECM hydrogel. MM conceived of the study, 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 32 
provided funding, oversaw the acquisition and analysis and also drafted the 
manuscript. All authors read and approved the manuscript. 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 33 
References 
[1] Nicholson C, Sykova E. Extracellular space structure revealed by diffusion analysis. Trends 
Neurosci. 1998;21:207-15. 
[2] Ashioti M, Beech JS, Lowe AS, Hesselink MB, Modo M, Williams SC. Multi-modal 
characterisation of the neocortical clip model of focal cerebral ischaemia by MRI, behaviour 
and immunohistochemistry. Brain Res. 2007;1145:177-89. 
[3] Smith EJ, Stroemer RP, Gorenkova N, Nakajima M, Crum WR, Tang E, et al. Implantation site 
and lesion topology determine efficacy of a human neural stem cell line in a rat model of 
chronic stroke. Stem Cells. 2012;30:785-96. 
[4] Bible E, Chau DY, Alexander MR, Price J, Shakesheff KM, Modo M. The support of neural 
stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials. 
2009;30:2985-94. 
[5] Park KI, Teng YD, Snyder EY. The injured brain interacts reciprocally with neural stem cells 
supported by scaffolds to reconstitute lost tissue. Nat Biotechnol. 2002;20:1111-7. 
[6] Bible E, Dell'Acqua F, Solanky B, Balducci A, Crapo PM, Badylak SF, et al. Non-invasive 
imaging of transplanted human neural stem cells and ECM scaffold remodeling in the 
stroke-damaged rat brain by (19)F- and diffusion-MRI. Biomaterials. 2012;33:2858-71. 
[7] Brown BN, Badylak SF. Extracellular matrix as an inductive scaffold for functional tissue 
reconstruction. Transl Res. 2014;163:268-85. 
[8] Massensini AR, Ghuman H, Saldin LT, Medberry CJ, Keane TJ, Nicholls FJ, et al. 
Concentration-dependent rheological properties of ECM hydrogel for intracerebral delivery 
to a stroke cavity. Acta Biomater. 2015;27:116-30. 
[9] Bible E, Chau DY, Alexander MR, Price J, Shakesheff KM, Modo M. Attachment of stem cells 
to scaffold particles for intra-cerebral transplantation. Nat Protoc. 2009;4:1440-53. 
[10] Wang AM, Cao P, Yee A, Chan D, Wu EX. Detection of extracellular matrix degradation in 
intervertebral disc degeneration by diffusion magnetic resonance spectroscopy. Magn 
Reson Med. 2015;73:1703-12. 
[11] Cheng HL, Islam SS, Loai Y, Antoon R, Beaumont M, Farhat WA. Quantitative magnetic 
resonance imaging assessment of matrix development in cell-seeded natural urinary 
bladder smooth muscle tissue-engineered constructs. Tissue Eng Part C Methods. 
2010;16:643-51. 
[12] Cheng HL, Loai Y, Farhat WA. Monitoring tissue development in acellular matrix-based 
regeneration for bladder tissue engineering: multiexponential diffusion and T2* for improved 
specificity. NMR Biomed. 2012;25:418-26. 
[13] Hu J, Liu C, Chen L, Xing W, Luan J. Volumetric measurement of polyacrylamide hydrogel 
injected for breast augmentation using magnetic resonance imaging. Exp Ther Med. 
2014;7:681-4. 
[14] Berdichevski A, Shachaf Y, Wechsler R, Seliktar D. Protein composition alters in vivo 
resorption of PEG-based hydrogels as monitored by contrast-enhanced MRI. Biomaterials. 
2015;42:1-10. 
[15] Yang X, Sun Y, Kootala S, Hilborn J, Heerschap A, Ossipov D. Injectable hyaluronic acid 
hydrogel for 19F magnetic resonance imaging. Carbohydr Polym. 2014;110:95-9. 
[16] Zhang Y, Sun Y, Yang X, Hilborn J, Heerschap A, Ossipov DA. Injectable in situ forming 
hybrid iron oxide-hyaluronic acid hydrogel for magnetic resonance imaging and drug 
delivery. Macromol Biosci. 2014;14:1249-59. 
[17] Modo M, Kolosnjaj-Tabi J, Nicholls F, Ling W, Wilhelm C, Debarge O, et al. Considerations 
for the clinical use of contrast agents for cellular MRI in regenerative medicine. Contrast 
Media Mol Imaging. 2013;8:439-55. 
[18] Naumova AV, Modo M, Moore A, Murry CE, Frank JA. Clinical imaging in regenerative 
medicine. Nat Biotechnol. 2014;32:804-18. 
[19] Ling W, Regatte RR, Navon G, Jerschow A. Assessment of glycosaminoglycan concentration 
in vivo by chemical exchange-dependent saturation transfer (gagCEST). Proc Natl Acad 
Sci U S A. 2008;105:2266-70. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 34 
[20] Saar G, Zhang B, Ling W, Regatte RR, Navon G, Jerschow A. Assessment of 
glycosaminoglycan concentration changes in the intervertebral disc via chemical exchange 
saturation transfer. NMR Biomed. 2012;25:255-61. 
[21] Liang Y, Bar-Shir A, Song X, Gilad AA, Walczak P, Bulte JW. Label-free imaging of gelatin-
containing hydrogel scaffolds. Biomaterials. 2015;42:144-50. 
[22] Kim M, Gillen J, Landman BA, Zhou J, van Zijl PC. Water saturation shift referencing 
(WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson 
Med. 2009;61:1441-50. 
[23] Jin T, Autio J, Obata T, Kim SG. Spin-locking versus chemical exchange saturation transfer 
MRI for investigating chemical exchange process between water and labile metabolite 
protons. Magn Reson Med. 2011;65:1448-60. 
[24] Jin T, Kim SG. Advantages of chemical exchange-sensitive spin-lock (CESL) over chemical 
exchange saturation transfer (CEST) for hydroxyl- and amine-water proton exchange 
studies. NMR Biomed. 2014;27:1313-24. 
[25] Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of 
intracellular proteins and peptides to detect pH effects in MRI. Nat Med. 2003;9:1085-90. 
[26] Modo M, Stroemer RP, Tang E, Veizovic T, Sowniski P, Hodges H. Neurological sequelae 
and long-term behavioural assessment of rats with transient middle cerebral artery 
occlusion. J Neurosci Methods. 2000;104:99-109. 
[27] Modo M. Long-term survival and serial assessment of stroke damage and recovery - 
practical and methodological considerations. J Exp Stroke Transl Med. 2009;2:52-68. 
[28] Stille M, Smith EJ, Crum WR, Modo M. 3D reconstruction of 2D fluorescence histology 
images and registration with in vivo MR images: application in a rodent stroke model. J 
Neurosci Methods. 2013;219:27-40. 
[29] Crum WR, Modo M, Vernon AC, Barker GJ, Williams SC. Registration of challenging pre-
clinical brain images. J Neurosci Methods. 2013;216:62-77. 
[30] Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and 
accurate linear registration and motion correction of brain images. Neuroimage. 
2002;17:825-41. 
[31] Zimmermann DR, Dours-Zimmermann MT. Extracellular matrix of the central nervous 
system: from neglect to challenge. Histochem Cell Biol. 2008;130:635-53. 
[32] Meng F, Modo M, Badylak SF. Biologic scaffold for CNS repair. Regen Med. 2014;9:367-83. 
[33] Schleich C, Muller-Lutz A, Zimmermann L, Boos J, Schmitt B, Wittsack HJ, et al. Biochemical 
imaging of cervical intervertebral discs with glycosaminoglycan chemical exchange 
saturation transfer magnetic resonance imaging: feasibility and initial results. Skeletal 
Radiol. 2016;45:79-85. 
[34] Ravindran S, Kotecha M, Huang CC, Ye A, Pothirajan P, Yin Z, et al. Biological and MRI 
characterization of biomimetic ECM scaffolds for cartilage tissue regeneration. 
Biomaterials. 2015;71:58-70. 
[35] Kotecha M, Klatt D, Magin RL. Monitoring cartilage tissue engineering using magnetic 
resonance spectroscopy, imaging, and elastography. Tissue Eng Part B Rev. 2013;19:470-
84. 
[36] Sasisekharan R, Raman R, Prabhakar V. Glycomics approach to structure-function 
relationships of glycosaminoglycans. Annu Rev Biomed Eng. 2006;8:181-231. 
[37] Cheng HL, Loai Y, Beaumont M, Farhat WA. The acellular matrix (ACM) for bladder tissue 
engineering: A quantitative magnetic resonance imaging study. Magn Reson Med. 
2010;64:341-8. 
[38] Nigmatullin R, Bencsik M, Gao F. Influence of polymerisation conditions on the properties of 
polymer/clay nanocomposite hydrogels. Soft Matter. 2014;10:2035-46. 
[39] Muller-Lutz A, Schleich C, Schmitt B, Antoch G, Matuschke F, Quentin M, et al. Gender, BMI 
and T2 dependencies of glycosaminoglycan chemical exchange saturation transfer in 
intervertebral discs. Magn Reson Imaging. 2015. 
[40] Onuki Y, Hasegawa N, Kida C, Obata Y, Takayama K. Study of the contribution of the state 
of water to the gel properties of a photocrosslinked polyacrylic acid hydrogel using 
magnetic resonance imaging. J Pharm Sci. 2014;103:3532-41. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 35 
[41] Ji K, Tsirka SE. Inflammation modulates expression of laminin in the central nervous system 
following ischemic injury. J Neuroinflammation. 2012;9:159. 
[42] Al'Qteishat A, Gaffney J, Krupinski J, Rubio F, West D, Kumar S, et al. Changes in 
hyaluronan production and metabolism following ischaemic stroke in man. Brain. 
2006;129:2158-76. 
[43] Li L, Liu F, Welser-Alves JV, McCullough LD, Milner R. Upregulation of fibronectin and the 
alpha5beta1 and alphavbeta3 integrins on blood vessels within the cerebral ischemic 
penumbra. Exp Neurol. 2012;233:283-91. 
[44] Huang L, Wu ZB, Zhuge Q, Zheng W, Shao B, Wang B, et al. Glial scar formation occurs in 
the human brain after ischemic stroke. Int J Med Sci. 2014;11:344-8. 
[45] Gates MA, Laywell ED, Fillmore H, Steindler DA. Astrocytes and extracellular matrix 
following intracerebral transplantation of embryonic ventral mesencephalon or lateral 
ganglionic eminence. Neuroscience. 1996;74:579-97. 
[46] Zaiss M, Xu J, Goerke S, Khan IS, Singer RJ, Gore JC, et al. Inverse Z-spectrum analysis for 
spillover-, MT-, and T1 -corrected steady-state pulsed CEST-MRI--application to pH-
weighted MRI of acute stroke. NMR Biomed. 2014;27:240-52. 
[47] Li H, Zu Z, Zaiss M, Khan IS, Singer RJ, Gochberg DF, et al. Imaging of amide proton 
transfer and nuclear Overhauser enhancement in ischemic stroke with corrections for 
competing effects. NMR Biomed. 2015;28:200-9. 
[48] van Zijl PC, Jones CK, Ren J, Malloy CR, Sherry AD. MRI detection of glycogen in vivo by 
using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S 
A. 2007;104:4359-64. 
[49] Desmond KL, Moosvi F, Stanisz GJ. Mapping of amide, amine, and aliphatic peaks in the 
CEST spectra of murine xenografts at 7 T. Magn Reson Med. 2014;71:1841-53. 
[50] Jin T, Wang P, Zong X, Kim SG. Magnetic resonance imaging of the Amine-Proton 
EXchange (APEX) dependent contrast. Neuroimage. 2012;59:1218-27. 
[51] Mezer A, Yeatman JD, Stikov N, Kay KN, Cho NJ, Dougherty RF, et al. Quantifying the local 
tissue volume and composition in individual brains with magnetic resonance imaging. Nat 
Med. 2013;19:1667-72. 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 36 
Figure Legends 
Figure 1. Characterizing the CEST effect of ECM hydrogel. A. In vitro z 
spectra of 8 mg/mL ECM hydrogel at different frequencies allowed us to assay if 
there are any chemical exchange sites that affect the magnetization transfer from 
the saturation signal (SSat) and could be exploited for a direct imaging approach. 
B. To more clearly visualize the exchange sites, the magnetization transfer 
asymmetry (MTRasym) was plotted to reveal distinct exchange sites at frequencies 
<750 Hz. The most pronounced effect in these sites was observed at 220 Hz, 
which was used for all subsequent imaging. C. CEST images at these 
frequencies for different exchange sites further illustrate the potential of this 
approach to afford a visualization of ECM hydrogel.  
 
Figure 2. Influence of experimental conditions on CEST signal. To evaluate 
how temperature and pH affect the detection of a specific signal from the 8 
mg/mL hydrogel upon implantation into the brain, temperature (21 °C, 30 °C, 37 
°C) and pH (5.5, 6.0, 6.5, 7.0) were arrayed with the acquisition of a full z spectra 
and displayed as MTRasym plots (A). Detection of ECM can be further affected by 
its concentration (2, 4, 6, 8 mg/mL), as well as its state being in liquid form (B) or 
cross-linked as a hydrogel (C). A 0 mg/mL condition, consisting of PBS only, 
served as a control. Pepsin is also added to the ECM preparation in a 
concentration-dependent fashion and could hence be a confounding factor, but 
no effect of pepsin on the CEST signal was found here at any concentration (D). 
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Figure 3. Detection of individual ECM components. A. MTRasym plots of 
individual ECM molecules found in ECM hydrogel. Specifically, Chondroitin 
Sulfate (CS), vitronectin (Vitro), collagen I (Coll I) and IV (Coll IV), fibronectin 
(Fib), Heparin Sulfate (Hep), hyaluronic acid (HA) and laminin (Lam) were 
evaluated as potential candidates for the signal detected in the ECM hydrogel 
preparation. As a potential confound in vivo, artificial cerebrospinal fluid (aCSF) 
was also assayed for its MTRasym. B. As CS and Fib exhibited individual MTRasym 
signal that resemble the ECM hydrogel when combined, both were combined into 
a single preparation to determine if these are the dominant source of the 
MTRasym in the ECM hydrogel. 
 
Figure 4. Acute in vivo detection of ECM hydrogel implanted in a stroke 
cavity. A. CEST imaging of 8 mg/mL ECM hydrogel 24 hours after injection into 
the stroke cavity in 3 different animals revealed a signal that corresponded to the 
expected coverage of the lesion cavity. B. Anterior-posterior slices further 
highlight the coverage of the entire lesion cavity and its validation by histological 
analysis (ECM hydrogel detected by collagen I staining). C. A more detailed 
examination of the correspondence between the CEST and histological detection 
of the ECM hydrogel reveal a good overlap (blue arrows), but also point out 
some discrepancies. In some cases, the CEST signal corresponded to the T2-
weighted lesion environment, but there was no evidence of ECM hydrogel 
present in this area (*). In other instances, a mismatch indicated a CEST signal in 
an area with damaged host tissue (*), but no significant ECM hydrogel being 
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present. D. Still, ECM hydrogel leaking into the lateral ventricle due to injection 
tract damage can be selectively visualized using this approach indicating its 
validity to assay the macroscopic distribution of ECM hydrogel injections. 
 
Figure 5. Stroke microenvironment-specific CEST signals and specificity of 
ECM hydrogel signal. A comparison of the CEST signal within the lesion cavity, 
homologous contralateral tissue, as well as the lateral ventricle reveal a weak 
(<5%) endogenous CEST signal at 1.8 ppm, which is upregulated in the lesion 
cavity (~8%). However, injection of ECM hydrogel within this same environment 
lead to an increase of the signal to >20% by 1 day post-implantation. 
 
Figure 6. Serial in vivo detection of ECM hydrogel implanted in a stroke 
cavity. To probe the utility of this imaging approach in monitoring the presence 
and potential biodegradation of the ECM hydrogel over time, serial MR imaging 
was performed prior to the injection of the ECM hydrogel (Pre), as well as 1, 3 
and 7 days post-implantation. To account for a baseline CEST signal, the pre-
implant images were subtracted from post-implant time points with thresholding 
of ±3 standard deviations (sd) being applied to filter out noise. MTRasym plots 
show the evolution of the signal inside the lesion cavity for individual animals. 
Histological analyses further corroborated the detection and distribution of ECM 
hydrogel based on collagen I staining, as well as the delineation of the lesion 
cavity based on glial scarring as indicated by GFAP staining.  
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Figure 7. Group comparison of CEST signal. A. To afford a group comparison, 
individual animals were co-registered and images were average to provide a 
representative mean group image for each time point. In MCAo only animals, no 
CEST signal was evident at any time point when accounting for the baseline 
signal and thresholding. For PBS (i.e. vehicle) injected animals, an acute signal 
change was observed. This was due to 1 animal having an elevated CEST signal 
on 1 day, potentially reflecting an increase in host chondroitin sulfate and 
fibronectin due to injection damage. However, a clear increase in CEST signal 
was evident in the ECM injected group at 1 day post-injection, but this signal 
gradually decrease by 3 days and no longer warranted detection at 7 days. B. 
Group MTRasym plots for signal inside the lesion cavity further supported the 
changes observed on the mean images. C. A representative histology image 
further corroborated the lack of ECM material in the lesion cavity in MCAo only 
and PBS animals, but a robust coverage in ECM hydrogel injected animals (*). In 
a PBS injected animal, an upregulation of collagen I (Coll I) was observed in the 
peri-infarct area (red arrow), but this was not evident in the MCAo only animals. 
In ECM hydrogel injected animals, there was also evidence of an upregulation of 
collagen I staining in the peri-infarct area including the lesioned cortex (blue 
arrow). However the degree of increase was markedly higher than in PBS 
animals and is likely to reflect some of the ECM hydrogel having permeated into 
this area during the injection procedure. 
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Figure 8. Histological validation of in vivo imaging. A. A direct comparison 
between the lesion environment and the CEST signal indicates that a strong 
signal (thresholded to 3 standard deviations of the contralateral hemisphere) can 
be detected in the stroke area in MCAo animals. The CEST signal detected here 
is hence not by itself specific to the ECM hydrogel, but is based on the CEST 
effect of ECM molecules that are also upregulated after a stroke. Indeed, 
collagen I (Coll I), chondroitin sulfate (CS) and fibronectin (Fib) are found to be 
significantly upregulated in the lesion area compared to the contralateral 
hemisphere and hence provide a biological source for this increase CEST signal. 
Nevertheless, the injection of an ECM hydrogel further enhances this 
endogenous signal, specifically in the area where ECM hydrogel was injected 
into the lesion cavity with chondroitin sulfate and fibronectin being strongly 
present within the injected material at 1 day, but less so at 7 days. At 7 days 
post-injection, this signal is reduced to baseline. Especially fibronectin appears 
reduced at 7 days within the ECM hydrogel, with chondroitin sulfate showing a 
less marked decrease and collagen I showing little difference to the 1 day time 
point. B. Overlay images for 1 and 7 days post-injection further highlight the 
differences in chondroitin sulfate and fibronectin (adjacent sections) in the ECM 
hydrogel (collagen I), as well as at the interface with damaged host tissue. 
Fibronectin and chondroitin sulphate are highly present within the ECM on day 1 
post-injection (i), but appear to be reduced by 7 days post-injection (ii). 
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Tables 
 
Component Concentration 
(mg/mL) 
Company Catalogue 
# 
Chondroitin 
Sulfate 
3 Sigma C9819 
Collagen I 3 BD 354236 
Collagen IV 1 Sigma C7521 
Fibronectin 1 Sigma F1141 
Heparin Sulfate 1 Sigma H7640 
Hyaluronic Acid 5 Sigma 53747 
Laminin 1 Sigma L2020 
Vitronectin 0.8 Sigma SRP3186 
 
Table 1. List of individual ECM components.  
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Supplementary Figures 
Supplementary Figure 1. MTRasym thresholding and signal evolution over 
time. To highlight the MTRasym above and below what can be considered noise 
and the standard endogenous signal, the mean MTRasym of the contralateral 
hemisphere was measured, including its standard deviation (sd), and a threshold 
of 3 sd was applied to yield a representation of the signal that was significantly 
above the baseline of non-damaged brain tissue. This thresholding afforded a 
visualization of the evolution of changes over time in MCAo only, as well as ECM 
implanted animals. It is evident here that there is a significant increase in 
MTRasym in the MCAo only control condition that needs to be subtracted to afford 
a visualization of the ECM hydrogel’s contribution to the MTRasym. 
 
Supplementary Figure 2. Baseline CEST signal subtraction and 
thresholding. To account for the baseline signal present within the stroke lesion, 
as well as the non-damaged brain, CEST images from the pre-implant time point 
were subtracted (Sub.) from post-implant time points. To eliminate noise from 
these images, a threshold was applied. In the MCAo only animals, it is evident 3 
standard deviations (sd) provide a sufficient threshold to eliminate noise from 
these images. Upon application of this approach to ECM hydrogel implanted 
animals, this afforded the selective visualization of the injected material to the 
CEST signal detected within the lesion cavity. 
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Supplementary Figure 3. Matristem detection. To ensure that our detection 
here is not specific to our preparation of ECM hydrogel, the equivalent 
commercially available preparation Matristem was also evaluated. Matristem 
yielded an equivalent detection (A) compared to the concentration used here (B), 
but provided a better distinction between different concentrations and produced a 
more robust effect. 
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